295 related articles for article (PubMed ID: 25341011)
21. How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?
Ciombor KK; Haraldsdottir S; Goldberg RM
Curr Colorectal Cancer Rep; 2014 Dec; 10(4):372-379. PubMed ID: 25395895
[TBL] [Abstract][Full Text] [Related]
22. Selection of biologics for patients with metastatic colorectal cancer: the role of predictive markers.
Kasi PM; Hubbard JM; Grothey A
Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):273-6. PubMed ID: 25579664
[TBL] [Abstract][Full Text] [Related]
23. Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypes.
San Lucas FA; Fowler J; Chang K; Kopetz S; Vilar E; Scheet P
Mol Cancer Ther; 2014 Dec; 13(12):3230-40. PubMed ID: 25349306
[TBL] [Abstract][Full Text] [Related]
24. First-Line Treatment of Metastatic Colorectal Cancer: Interpreting FIRE-3, PEAK, and CALGB/SWOG 80405.
Elez E; Argilés G; Tabernero J
Curr Treat Options Oncol; 2015 Nov; 16(11):52. PubMed ID: 26374340
[TBL] [Abstract][Full Text] [Related]
25. The role of genome sequencing in personalized breast cancer prevention.
Sieh W; Rothstein JH; McGuire V; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2322-7. PubMed ID: 25342391
[TBL] [Abstract][Full Text] [Related]
26. [Targeted therapies for metastatic colorectal cancer].
Kito Y; Yamazaki K
Nihon Rinsho; 2015 Aug; 73(8):1384-90. PubMed ID: 26281694
[TBL] [Abstract][Full Text] [Related]
27. The impact of genomics on public health practice.
Burton H; Jackson C; Abubakar I
Br Med Bull; 2014 Dec; 112(1):37-46. PubMed ID: 25368375
[TBL] [Abstract][Full Text] [Related]
28. 'Deepness of Response' Is Associated with Overall Survival in Standard Systemic Chemotherapy for Metastatic Colorectal Cancer.
Nozawa H; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Watanabe T
Chemotherapy; 2014; 60(5-6):360-7. PubMed ID: 26389969
[TBL] [Abstract][Full Text] [Related]
29. Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol.
Hendlisz A; Deleporte A; Vandeputte C; Charette N; Paesmans M; Guiot T; Garcia C; Flamen P
BMJ Open; 2015 Mar; 5(3):e007189. PubMed ID: 25753361
[TBL] [Abstract][Full Text] [Related]
30. Management of colorectal cancer.
Stintzing S
F1000Prime Rep; 2014; 6():108. PubMed ID: 25580262
[TBL] [Abstract][Full Text] [Related]
31. Reporting genomic secondary findings: ACMG members weigh in.
Scheuner MT; Peredo J; Benkendorf J; Bowdish B; Feldman G; Fleisher L; Mulvihill JJ; Watson M; Herman GE; Evans J
Genet Med; 2015 Jan; 17(1):27-35. PubMed ID: 25394173
[TBL] [Abstract][Full Text] [Related]
32. The UCSC Cancer Genomics Browser: update 2015.
Goldman M; Craft B; Swatloski T; Cline M; Morozova O; Diekhans M; Haussler D; Zhu J
Nucleic Acids Res; 2015 Jan; 43(Database issue):D812-7. PubMed ID: 25392408
[TBL] [Abstract][Full Text] [Related]
33. Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer.
Garcia-Closas M; Gunsoy NB; Chatterjee N
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25392194
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield.
Ankala A; da Silva C; Gualandi F; Ferlini A; Bean LJ; Collins C; Tanner AK; Hegde MR
Ann Neurol; 2015 Feb; 77(2):206-14. PubMed ID: 25380242
[TBL] [Abstract][Full Text] [Related]
35. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
[TBL] [Abstract][Full Text] [Related]
36. Impact of genetic counseling and Connexin-26 and Connexin-30 testing on deaf identity and comprehension of genetic test results in a sample of deaf adults: a prospective, longitudinal study.
Palmer CG; Boudreault P; Baldwin EE; Sinsheimer JS
PLoS One; 2014; 9(11):e111512. PubMed ID: 25375116
[TBL] [Abstract][Full Text] [Related]
37. Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition.
Patrick-Miller LJ; Egleston BL; Fetzer D; Forman A; Bealin L; Rybak C; Peterson C; Corbman M; Albarracin J; Stevens E; Daly MB; Bradbury AR
JMIR Res Protoc; 2014 Oct; 3(4):e49. PubMed ID: 25355401
[TBL] [Abstract][Full Text] [Related]
38. Cancer information seeking in the digital age: effects of Angelina Jolie's prophylactic mastectomy announcement.
Noar SM; Althouse BM; Ayers JW; Francis DB; Ribisl KM
Med Decis Making; 2015 Jan; 35(1):16-21. PubMed ID: 25349187
[TBL] [Abstract][Full Text] [Related]
39. The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.
Moldovan R; Keating S; Clancy T
Fam Cancer; 2015 Mar; 14(1):51-60. PubMed ID: 25342222
[TBL] [Abstract][Full Text] [Related]
40. [Having a child and PND/PGD access in women with a BRCA1/2 mutation? Different approach whether ill or healthy].
Pellegrini I; Prodromou N; Coupier I; Huiart L; Moretta J; Noguès C; Julian-Reynier C
Bull Cancer; 2014 Nov; 101(11):1001-8. PubMed ID: 25418592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
